Delivery Order SPE2DB25D3504-SPE2DB25FVWFP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,165.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a $5,790.67 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tobradex Eye Ointment (3.5 grams). This firm fixed-price contract, which closes on July 22, 2025, represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is non-competitive and does not utilize a set-aside designation. Performance will occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,581.72 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,850.39 to supply Tobradex eye ointment (3.5 grams) under a firm fixed price contract. The award was made on July 3, 2025, with an ultimate completion date of July 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical distributor and critical federal...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 25, 2025, for Tobrex 0.3% eye ointment (3.5 gm) with a ceiling value of $2,392.58. This is a firm fixed price, non-set-aside contract supporting the Defense Logistics Agency's Medical Supply Chain, with a completion deadline of July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Tobrex 0.3% eye ointment (3.5 grams), with a contract ceiling value of $1,022.82. The order represents a firm fixed-price delivery against an existing Indefinite Delivery Contract and carries an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the place of performance for this award—serves as a major...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Tobrex 0.3% eye ointment in 3.5-gram units, with a ceiling value of $1,227.93. This firm fixed-price delivery order is scheduled for completion by June 2, 2025, and represents a non-competitive set-aside procurement. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, and the product will be...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,130 to Amerisourcebergen Drug Corporation for Tobradex eye ointment. The order is to be fulfilled by Amerisourcebergen's corporate office in Conshohocken, Pennsylvania and completed within one day, between June 21 and June 22, 2023. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will deliver the requested Tobradex eye ointment in...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobradex Eye Ointment 3.5GM. The contract has a firm fixed price, a ceiling value of $1,108.89, and a period of performance through March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWFPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Tobradex Eye Ointment (3.5gm) with a ceiling value of $1,639.13 under a firm fixed-price delivery order contract. This award is a non-set-aside, competitively awarded contract executed through the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The place of performance is located in Conshohocken, PA, with an ultimate completion date of September 8, 2025. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's status as a prime vendor under this significant contract vehicle demonstrates its capability to fulfill federal medical supply requirements through competitive procurement processes and positions it to support Defense Health Agency and other government healthcare systems' pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/5/25 |